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Concerns with Taking the COVID-19 Vaccine
Kaela Bellamy and Robert S. Keyser (Faculty Advisor)
Kennesaw State University
ABSTRACT
This IRB-approved descriptive study provides an overview of the concerns associated with
receiving a COVID-19 vaccination within the Kennesaw State University (KSU) community,
an R2 university with over 41,000 students, and uses a survey to provide insight into how
students, faculty, staff, and administrators are responding to the vaccinations for COVID-19,
both available and unavailable, and their preferences. Our research findings indicate that: 1)
The majority of survey responses at KSU intend to receive the vaccine, regardless of their
concerns; 2) The majority of the participants who are either employed or provided an education
by Kennesaw State University plan to get their vaccination for COVID-19 at one of the campus
locations; 3) If given a choice, 32.17% preferred the Moderna vaccine, while 26.96% opted for
Pfizer, and 37.39% of respondents preferred not to answer; and 4) The primary concerns of
survey responses were associated with the direct side effects as well as the unknown long-term
effects of receiving either vaccine..
Keywords: COVID-19 vaccine, Pfizer, Moderna, direct side effects, long-term effects,
Kennesaw State University
Introduction
The SARS-CoV 2 (COVID-19)
pandemic has affected millions of people
globally. Prior to the Fall 2020 semester,
Kennesaw State University (KSU), which
had over 41,000 students and has been
classified as an R2 university,
implemented a number of safety protocols
following guidelines from the Centers for
Disease Control and Prevention (CDC) as
well as the University System of Georgia
(USG). In December 2020, the Food and
Drug Administration (FDA) approved
both the Pfizer and Modera vaccines for
the prevention of the coronavirus disease
2019 (COVID-19).
KSU is now a distributor of the
COVID-19 vaccine to faculty, students,
and staff. As more of the population in
Georgia are eligible to receive the vaccine,
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concerns are rising. The university is
offering the Pfizer and Moderna vaccine,
depending on what is available at the time.
Personal preferences and opinions affect
decisions regarding receiving the vaccine
and which vaccine to receive. The
growing
concerns
around
both
vaccinations are affecting personal
opinions. At the beginning of the Spring
2021 semester, this IRB-approved
descriptive study was designed to provide
an overview of the concerns associated
with receiving a COVID-19 vaccination
within the KSU community and uses a
survey to provide insight into how
students, faculty, staff, and administrators
are responding to the vaccinations for
COVID-19,
both
available
and
unavailable, and their preferences.
Discovering vaccination concerns will
allow KSU to advertise vaccinations
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effectively and continue to educate their
students, faculty, and staff.
Literature Review
Reports of the COVID-19 coronavirus
first surfaced in December 2019
(Borowiak et al., 2020) but gained
worldwide attention in January 2020 when
the World Health Organization (WHO)
declared the COVID-19 outbreak a
“public health emergency of international
concern” (Kennedy, 2020, p. 15). The
COVID-19 disease is caused by a
coronavirus called SARS-CoV-2.
Transmission is mainly through
respiratory droplets and close contact with
others, similar to how influenza is spread
(Song, 2020). On average, symptoms
occur about five days after exposure to the
virus and almost all patients develop
symptoms within 12 days of exposure to
the virus (Wiersinga & Prescott, 2020).
The human-to-human spread of COVID19 has an estimated reproduction rate of
Ro = 2.28, which means each infected
person will infect an average of 2.28
people (Williams & Cañon-Montañez,
2020). In February 2020, the Centers for
Disease Control (CDC) provided
guidelines on how to protect oneself and
others (Coronavirus disease 2019
(COVID-19), 2019). On March 11, 2020,
the
Director-General
of the World Health Organization
characterized COVID-19 as a pandemic in
his opening remarks at a media briefing
(WHO, 2020).
A review of the literature reveals that
people most susceptible to serious adverse
effects of COVID-19, including mortality,
are members of vulnerable populations:
infants, the elderly, women, LGBTQ
individuals, African Americans, prisoners,
parent caregivers of children with
intellectual disabilities, and college

https://digitalcommons.kennesaw.edu/kjur/vol9/iss1/2

students. Gale et al. (2020) in the United
Kingdom (UK) concluded that SARSCoV-2, or COVID-19, infection is
uncommon in babies admitted to a
hospital, although some babies are
infected and a few are infected with
serious symptoms (66 babies with
confirmed SARS-CoV-2 in their study
between March 1 – April 30, 2020). In a
population-based study in the UK
conducted by Forbes et al. (2020), their
findings reveal that there is no evidence of
serious harm from COVID-19 to adults
living in households with children
compared to those living in households
without children. A separate study
conducted in the U.S. (Weisberg et al.,
2021) deduced that clinical manifestations
of COVID-19 are associated with age.
Whereas adults may develop respiratory
symptoms leading to acute respiratory
distress syndrome (ARDS) in the most
severe form, children are largely spared
from respiratory illness; however, they
can develop a life-threatening multisystem
inflammatory syndrome (MIS-C). In a
prospective study of 49 children
confirmed
with
SARS-CoV-2
in
Shanghai, China, asymptomatic SARSCoV-2 infection may be common in
children, and viral RNA detected in the
stool sheds in a similar pattern as in
symptomatic cases (Cai et al., 2020). An
American cohort study of children and
adolescents under 21 years of age found
that children confirmed with SARSCoV-2 infection typically have mild
symptoms that do not require medical
attention (Hurst et al., 2020).
Although COVID-19 threatens the
lives of children in general, the social and
economic consequences are greater
among female children. Spangaro et al.
(2013) cites that women and girls are
disproportionately affected in times of
conflict and crisis. Previous epidemics
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have shown that violence against females
can increase in scale due to social and
economic consequences, as shown during
the Ebola epidemic (Onyango et al.,
2019). In a prospective study involving
764 female patients in Poland, Fuchs et al.
(2020) report that the COVID-19
pandemic affects many different aspects
of human health, including quality of
sexual lifestyle and frequency of
intercourse, such that certain relationships
between partners declined and levels of
stress and anxiety increased. Potter et al.
(2020) reveal that perceptions of COVID19 threat were greater among both lesbian
and bisexual women versus heterosexual
women, which could be explained by
either knowing someone who had been
diagnosed with COVID-19 or by their
perception that their workplace put them
at risk of contracting COVID-19.
COVID-19 increases levels of stress
and anxiety for many women, especially
those who are also included in other
vulnerable populations. For example,
compared to heterosexual women,
LGBTQ female children are at an even
higher risk of anxiety and stress. LGBTQ
youth are at a disproportionate risk for
depression (Russell & Fish, 2016).
Woznicki et al. (2020) report that high
parasocial relationship strength—oneway relationships with LGBTQ media
personalities on platforms such as
YouTube—weakened the associations
between family support and loneliness and
between loneliness and depression. Two
lifestyle casualties of the COVID-19
lockdowns in the LGBTQ community
suggested by Musto (2020) include the
loss of personal touch (i.e., interactions
with others and spontaneity) and solitude
(i.e., working from home, shopping
online, and watching movies alone).
Goldbach et al. (2020) suggest the use of
resilience through increasing social
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support, community connectedness, and
engagement in provider-guided and selfguided distress coping interventions, as a
means to buffer the impact of COVID-19
pandemic concerns among the LGBTQ
community.
In addition to age, gender, and
orientation, ethnicity can increase
COVID-19
susceptibility.
African
Americans experience disproportionately
high rates of infection and mortality
relative to other populations in the United
States (Kemp et al., 2020; Reyes, 2020).
Counties with higher proportions of
African Americans have higher numbers
of COVID-19 cases and mortalities, due in
part to crowded living conditions, higher
unemployment, lack of health insurance,
and increased levels of chronic disease
(Millett et al., 2020). Moreover, African
Americans are more likely to be poor, be
employed as ‘essential’ workers in lowpaying service jobs, and experience poor
physical health compared to other
racial/ethnic populations in the U.S.
(Yancy, 2020). The American Civil
Liberties Union (ALCU) contends that
African Americans are more likely to use
public transportation in large urban areas
which places them in closer contact with
others resulting in an increased level of
vulnerability to becoming infected with
COVID-19 (FDA, 2020). Reyes (2020)
attributes the overrepresentation of
African Americans among confirmed
COVID-19 cases and the number of
deaths as a reflection of existing social
inequalities tied to race, class, access to
the health care system, and social
exclusion (Kim & Bostwick, 2020).
Gilmore (2020) suggests the primary
driver of death disparities from
COVID-19 among African Americans is
economic inequality, which impacts
where and how people live and the kind of
community they have to exist within.
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Guerrero & Orlowski-Scherer (2020) note
that people of color are dying from
COVID-19 at higher rates than white
Americans, with African Americans dying
at rates three times greater than their share
of the population.
Systemic issues in the U.S. are
affecting more than the COVID-19 rates in
the African American population. The
pandemic has revealed systemic problems
in U.S. prisons and jails, such as rampant
overcrowding, an aging population, and a
population demonstrating high rates of
underlying health conditions, which are
triggers for prisoners suffering from
severe illness or mortality from
COVID-19 (Wang et al., 2020). Further,
many prisoners live in crowded
dormitories with common toilets and
showers and, as such, are unable to follow
the most basic social distancing or handwashing practices recommended by the
Centers for Disease Control (Parloff,
2020). As a result, advocacy groups,
public health experts, and lawmakers have
called on government officials for the
early release of inmates, particularly nonviolent offenders, to free up space in
prisons and jails in order to prevent the
potential for a rapid spread of COVID-19
(Newman, 2020).
Like confinement in jails, confinement
in homes has played a large role in the
COVID-19 pandemic. In an international
cross-disciplinary online survey, findings
reveal that social and physical inactivity,
triggered by home confinement during the
COVID-19 pandemic, was associated with
lower mental and emotional well-being
(Ammar et al., 2020). Hamblaw et al.
(2021) report distraction and acceptance
are the most common coping strategies,
and that positive reframing is the most
beneficial coping strategy to mitigate the
negative mental health effects of COVID-
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19. For parent caregivers of children with
intellectual disabilities, mental health
problems were exacerbated when
providing care in households with more
severe challenging behavior and greater
financial
pressures,
while
also
experiencing lower levels of social
support compared to parents of children
without intellectual disabilities (Willner et
al., 2020).
Caregivers include those caring for
their children as much as it includes those
caring for the older adult population.
Andrew et al. (2020) report that older
adults have been disproportionately
affected by the COVID-19 pandemic,
particularly, in Long-Term Care Facilities
(LTCFs), due to varying degrees of frailty,
vulnerability, and resilience among older
people, which makes them vulnerable to
poor health outcomes. Further, among the
elderly LTCF residents, a nutritional
deficit combined with advanced age and
the presence of chronic health conditions,
such as hypertension, increases the
vulnerability to a severe case of COVID19 (Araújo et al., 2021). The effects of
COVID-19 have led to an increase in
mortality rates among the elderly, who are
at an increased risk of a weaker immune
system and comorbidities (Duru, 2020).
During
hospitalization,
significant
functional decline is attributed to severe
muscle weakness and atrophy among the
elderly diagnosed with COVID-19
infection (Sagarra-Romero & ViñasBarros, 2020). In a study of elderly people,
researchers have discovered that COVID19 safety measures (Heidinger & Richter,
2020) and the digital divide (Martins Van
Jaarsveld, 2020) have a negative impact
on loneliness, a risk factor for physical and
mental illness.
Issues that have surfaced on college
campuses
during
the
COVID-19
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pandemic include addressing the needs of
college students with special needs
(Gould, 2020), managing the mental
health of students (Aufderheide &
Gondles, 2020; Son et al., 2020),
protecting the safety and well-being of the
student LGBTQ+ community (Weissman,
2020; Wood, 2020), and the effects and
added responsibilities absorbed by the
faculty (Alexander, 2020). College
campuses have a large, diverse, and
vulnerable population that is affected by
COVID-19. LGBTQ, African American,
women, elderly, young student, and
caregiver populations all have one thing in
common: they are all a part of college
campuses across the world and a part of
KSU.

one will students, faculty, staff, and
administrators choose: Pfizer or Moderna?

Methodology

The demographic composition of
participants in this study is quite broad. Of
the 125 responses to Q6, “Please select
your Age Group,” Table 1 shows 24% are
in the 18-39 age group. There were 48.8%
in the 40-59 age group, and 26.4% in the
60 and over age group.

The data collection method was an
online survey that was created using
Qualtrics XM (see Appendix 1) and then
posted in Kennesaw State University’s
email newsletter KSU Today, so students,
faculty, staff, and administrators that
comprise the KSU community could
complete it at their own will. The survey
consisted of nine questions, including
eight multiple-choice questions and one
free-response question. All questions were
directed towards the general KSU
population and were focused on subjects
that pertained to receiving the COVID-19
vaccine and concerns regarding the
currently available vaccines: Pfizer or
Moderna. The following four research
questions (RQ) will be explored:

RQ4: What concerns do participants have,
if any, with taking the COVID-19 vaccine?
At the end of the survey period,
Qualtrics XM generated a report with all
responses—131 of which were used to
conclude the findings of the research. A
response is considered useful if it
contributes to the research in any way. To
interpret the responses, descriptive
statistics generated by Qualtrics XM
were used to analyze the answers to the
multiple-choice questions while the
answers to the free-response questions
were used to provide more detailed insight
for the researchers.

RQ1: When students, faculty, staff, and
administrators become eligible for the
vaccine, do they intend to receive it?
RQ2: If one chooses to take the vaccine,
where do they intend to take it?
RQ3: If given a choice of vaccines, which
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Table 1. Demographic Composition by Age
#
1
2
3

Answer
18-29
30-39
40-49

%
4.00%
20.00%
19.20%

Count
5
25
24

4
5
6
7
8

50-59
60-69
70-79
80+
Prefer not to answer

29.60%
23.20%
3.20%
0.00%
0.80%

37
29
4
0
1

Total

100%

125

Further, Table 2 reveals that out of the
125 responses, most participants identified
as White/Caucasian (80%), followed by

Prefer
not
to
answer
(6.40%),
Black/African American (5.60%), Asian
(4.80%), and Hispanic or Latino (3.20%).

Table 2. Demographic Composition by Race and/or Ethnicity
#
1

Answer
American Indian or Alaskan Native

%
0.00%

Count
0

2
3

Asian
Black/African American

4.80%
5.60%

6
7

4
5

Hispanic or Latino
Native Hawaiian or other Pacific Islander

3.20%
0.00%

4
0

6
7

White/Caucasian
Prefer not to answer
Total

80.00%
6.40%
100%

100
8
125
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Table 3 reveals that 92.80% of
respondents identified as either Staff,
Faculty, or Administrator, and 7.20% of

respondents to this question identified as
either Student, Other, or Prefer not to
answer.

Table 3. Demographic Composition by Role at KSU
#
1
2
3
4
5
6

Answer
Student
Staff
Faculty
Administrator
Other
Prefer not to answer
Total

Table 4 reveals the demographics
based on gender. Most of the participants
are women, which does affect the
responses to the research questions.
Although there is not a diverse range in

%
3.20%
48.00%
36.80%
8.00%
1.60%
2.40%
100%

Count
4
60
46
10
2
3
125

gender, there is one person that identified
as “other”, implying that we had at least
one participant who is in the LGBTQ
community.

Table 4. Gender
#
1
2
3
4

Answer
Woman
Man
Prefer not to answer
Other
Total

Demographics heavily affect the
research because they identify the
vulnerable populations that are in the KSU
community. The various populations
should be taken into consideration when
analyzing the results and reaching
conclusions.
Analysis/Results
At the end of the survey period,
Qualtrics XM provided the survey
responses to the free-response questions
as well as descriptive statistics for the
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%
81.60%
16.80%
0.80%
0.80%
100%

Count
102
21
1
1
125

multiple-choice questions. Considering
both the multiple-choice questions and the
free-response question, a full analysis of
students,
faculty,
staff,
and
administrators’ decisions and perceptions
of the Pfizer and Moderna COVID-19
vaccines was conducted based on a total of
132 total responses, of which 131
responses were found to be useful. One
response was not useful because the
participant opted out of the survey on the
first question. Participants were informed
that they could opt out of the survey or
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skip questions without consequence.
RQ1: When students, faculty, staff, and
administrators become eligible for the
vaccine, do they intend to receive it?
In response to Question 1, Table 5
reveals that 80.0% intended to or had

already taken either the Pfizer or Moderna
vaccine, 4.0% did not intend to receive the
vaccine, either due to their concerns or
because they did not want the vaccine, and
16.0%
of
respondents
remained
undecided. Students, faculty, staff, and
administrators had some remaining
concerns that are crucial to their decision.

Table 5. Responses to RQ1: When you become eligible, do you intend to take the COVID-19
vaccine?
#
1
2
3
4

Answer
Yes
No
Undecided
Prefer not to answer
Total

RQ2: If one chooses to take the vaccine,
where do they intend to take it?
Table 6 indicates that, whereas 81.60%
of participants intended to receive the
vaccine from KSU, 3.20% chose not to

%
80.00%
4.00%
16.00%
0.00%
100%

Count
100
5
20
0
125

take the vaccine, and 4.0% preferred not
to answer. Many of the participants that
are either employed or provided an
education by KSU, however, planned to
get their vaccination for COVID-19 at one
of the campus locations.

Table 6: Responses to RQ2: If you take the COVID-19 vaccine, where will you take it?
#
1
2
3
4
5

Answer
At KSU
Your pharmacy
Your healthcare provider
Will not take the vaccine
Prefer not to answer
Total

RQ3: If given a choice of vaccines, which
one will students, faculty, staff, and
administrators choose: Pfizer or Moderna?
Pfizer and Moderna were the only two
vaccines currently being offered at
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%
81.60%
3.20%
8.00%
3.20%
4.00%
100%

Count
102
4
10
4
5
125

Kennesaw State University. KSU did not
specify which vaccine will be
administered in advance because they
were unaware of which vaccine will be
available at a participant’s scheduled
appointment. When given a choice,
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Table 7 revealed, 32.17% of participants
chose Moderna, while 26.96% opted for

Pfizer. Notably, 37.39% of
participants preferred not to answer.

the

Table 7. Responses to RQ3: If given a choice of vaccines which do you prefer?
#
1
2
3
4

Answer
Pfizer vaccine
Moderna vaccine
Will not take the vaccine
Prefer not to answer
Total

RQ4: What concerns do you have, if any,
with taking the COVID-19 vaccine?
When directly asked if the participants
had any concerns, 52 responses said yes,
according to Table 8. Even those who are
choosing the Pfizer or Moderna vaccines
had remaining worries. Ultimately,
according to our sample, most of the
population at KSU intended to receive the
vaccine, regardless of their concerns. At
least four participants were directly
concerned about the mRNA technology
that was present in both the Pfizer and

%
26.96%
32.17%
3.48%
37.39%
100%

Count
31
37
4
43
115

Moderna vaccines. Two participants
mentioned that they intended to wait to
receive a vaccine that was not provided to
the public at the time of this survey
(Johnson & Johnson or Astra Zeneca).
Johnson & Johnson was awaiting approval
and was approved within weeks after the
survey was conducted. Astra Zeneca was
available in other countries, but not the
United States. From our results, it was
apparent that there are many concerns, but
people were making their choices
according to what they felt is personally
best for them.

Table 8. Responses to RQ4: Have you any concerns about taking the COVID-19 vaccine?
#
1
2
3
4

Answer
Yes
No
Not sure
Prefer not to answer
Total

Responses to the free-response
question, Q5, are summarized in Table 9.
Among the 41.60% of participants who
expressed concern with taking the
COVID-19 vaccine (from Table 8), 88
concerns were shared in the survey. The
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%
41.60%
48.80%
8.00%
1.60%
100%

Count
52
61
10
2
125

primary concerns pertained to both the
direct side effects experienced after taking
the vaccine followed by long-term side
effects. Some of the direct side effects
listed were allergic reactions, aches, and
pains (27.27%). Long-term effects
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(27.27%) were followed by not enough
information was known (i.e., lack of
testing, conflicting information, etc.)
(10.23%). Following the long-term effects
and lack of information, the concerns were
primarily with pregnancy, fertility, and
effects on babies (7.95%), efficacy of the
current vaccines (6.82%), and ethical
concerns (4.55%). 15.91% mentioned
concerns that did not have their own
category, so they were listed as Other (i.e.,
trust, on-time availability of the vaccine,
awaiting approval of a different vaccine,
etc.).
According to the free-response
question, Q5, eight participants were

concerned with the actual process of
receiving the vaccine. The facility in
which the vaccine was given could have
played a part in their concern. Three
participants voiced that they were
concerned that their chosen location
would not administer the second dose on
time or have it available. One participant
mentioned that they were concerned about
not being able to pick the vaccine that they
received because KSU was not able to
specify in advance which will be
available. Location was a determining
factor for some to feel safe. Regardless,
most of the participants chose to receive
the Pfizer or Moderna vaccine at KSU
when they became eligible.

Table 9: Responses to RQ4: What concerns do you have, if any, with taking the COVID-19
vaccine?
#
1
2
3

4
5
6
7

Answer
Direct side effect
Long-term effects
Not enough is known
(lack of testing, conflicting
information, etc.)
Pregnancy, fertility, babies
Efficacy of vaccine
Ethical concerns
Other
Total

https://digitalcommons.kennesaw.edu/kjur/vol9/iss1/2

%
27.27%
27.27%
10.23%

Count
24
24
9

7.95%
6.82%
4.55%
15.91%
100%

7
6
4
14
88
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Although 15.79% of participants
expressed concerns regarding the need for
more testing and research about the longterm side effects, only 11.11% of
participants believed that the vaccine
testing and production were rushed. One
participant mentioned that they believed
there was a microchip in the vaccine, and
they were concerned about how that would
have affected the future. Some mentioned
they were unsure of how long the vaccine
would be effective, while others believed
it would have only protected against few
strains of the coronavirus. There were four
concerns about complications with their
preexisting conditions, such as heart and
autoimmune diseases.
Also shown in Table 9, 7.95% of
concerns raised dealt with fertility,
pregnancy, and babies. One response
mentioned that they feel the effect on
fertility and pregnancy is not discussed
enough and should have been a priority in
the testing of the vaccinations. When
testing the vaccinations, 3.53% believed
that there was unethical testing, including
testing on embryos. Their concern was
revolved around the process of how the
vaccine was produced and tested, rather
than the direct effects.
Discussions
An IRB-approved descriptive study
was conducted by distributing a survey
among the KSU community, which
consists of students, faculty, staff, and
administrators to determine the level of
interest in taking the available vaccine
when people become eligible and to
identify concerns with taking the COVID19 vaccine. The following research
questions were explored, along with their
respective conclusions:
RQ1: When students, faculty, staff, and
administrators become eligible for the
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vaccine, do they intend to receive it?
Most of the respondents at KSU intend
to receive the vaccine, regardless of their
concerns.
Considering the passion around the
debate of the vaccine, it is surprising that
the majority of those who responded to the
survey decided to receive the vaccine. The
participants admit that there are concerns
around the vaccine, but that does not stop
them from receiving it. Based on
demographics, a large portion of the
participants was from a vulnerable
population. For example, about 80% of the
participants were women (see Table 4).
Vulnerable populations have different
reasons to be worried than nonvulnerable,
like fertility for women. That being said, it
is clear that possible long-term side effects
are not preventing most from receiving the
vaccine.
RQ2: If one chooses to take the vaccine,
where will they intend to take it?
Most of the participants that are either
employed or provided an education by
KSU plan to get their vaccination for
COVID-19 at one of the campus locations.
KSU has offered the vaccine to students,
faculty, staff, and administrators as they
became eligible to receive it. Although the
university offered the Moderna and Pfizer
vaccine on campus, other options remain,
including the participant’s pharmacy and
healthcare provider.
If a participant chose not to receive it
on campus, there could have been many
factors. The participant could have been
unsure, chosen to receive the vaccine in
another manner, had other concerns, or
possibly awaited the availability of a
different vaccine. KSU made it clear that
it offered the Moderna and Pfizer vaccine,
but it also made it known that you would
not get the option of which vaccine you
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would like. The vaccine you received
would depend on what was available and
the location that you attended. If a student,
staff, or faculty member wanted to receive
a specific vaccine, it would have been in
their best interest to receive it from a
different provider that could guarantee
which vaccine they received.
KSU updated students, faculty, staff,
and administrators through frequent email
communication and announcements,
which allowed the KSU community to
continually become aware of new
knowledge as the pandemic evolved. This
could have explained why a high
percentage of the participants from the
same population intended on receiving
their vaccine through the school.

concerns. They will have to understand all
vaccines and the concerns that come with
them. For example, women who are
concerned with fertility may have rather
picked a vaccine that has already done
some studies on fertility rather than one
who has not researched it yet.
RQ4: What concerns do you have, if any,
with taking the COVID-19 vaccine?

If given a choice, 32.17% preferred the
Moderna vaccine, while 26.96% opted for
Pfizer, and 37.39% of respondents
preferred not to answer (see Table 7).
Those that preferred not to answer
indicated that they may have been unsure,
did not have enough information, or were
awaiting FDA approval of a different
vaccine, according to some concerns
voiced in the free- response question.

The primary concerns with taking the
COVID-19 vaccine are the direct and
unknown long-term effects followed by
not enough information is known (e.g.,
lack of testing, conflicting information,
which vaccine will be administered) about
current vaccines and their future effects. It
is important to note that vulnerable
populations have more concern, indicated
by the demographics of the participants,
with taking the vaccine. The long-term
effects could be a range of problems,
including fertility issues or how it affects
babies. Future and present parents do not
know what effects the vaccination will
have on their children. Other populations,
such as the elderly, may be affected more
by the side effects due to their
vulnerability in their immune system.
Some of the vulnerable populations
believe there are ethical concerns with
how the vaccine was tested and is being
produced.

Although about 60.0% of respondents
had an opinion on which vaccine they
would receive, it is clear that not all of
them were able to choose since 81.20%
were planning on receiving the vaccine
from KSU (see Tables 5 and 6). In other
words, those that are receiving their
vaccine from KSU will have to be
educated on all vaccines since they will be
given what is currently available rather
than picking the one that they would like.
For some of the vulnerable populations,
that could have contributed to their

Vulnerable populations help make up
the KSU community. It is important to
recognize the effects that the COVID-19
pandemic has had on KSU and continues
to have. Previous researchers examined
individual vulnerable populations and how
COVID-19 affected them, but this study
looked at findings for a population full of
vulnerable people and examined their
response to the recommended way to stay
safe from COVID-19. This study
recognizes the overlap of vulnerable
populations and tries to understand

RQ3: If given a choice of vaccines, which
one will students, faculty, staff, and
administrators choose: Pfizer or Moderna?

https://digitalcommons.kennesaw.edu/kjur/vol9/iss1/2
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opinions towards the response to
COVID-19. Other studies, including some
referred to in the literature reviews,
focused on the period before the vaccine
was available, while this study focuses on
the next step in the pandemic where
possible solutions are being proposed.
While the concerns regarding the vaccine
within the KSU community were
explored, there was also discussion of how
they related to various vulnerable
populations. Exploring the opinions on
receiving the vaccine is important to help
KSU and the surrounding community
understand how they can best respond to
the population and aid their peers.
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Appendix 1 – Qualtrics Survey
IRB-FY21-388
Concerns With the COVID-19 Vaccine
In this survey, we would like to collect
some feedback about your concerns, if any,
with taking the COVID-19 vaccine. Your
participation in the survey is completely
voluntary and anonymous.

Next, we would like to collect some
demographic data.
6. Please select your age group.

1. When you become eligible, do you

intend to take the COVID-19 vaccine?
Yes
No
Undecided
Prefer not to answer
2. If you take the COVID-19 vaccine,

where will you take it?
At KSU
Your pharmacy
Your healthcare provider
Will not take the vaccine
Prefer not to answer

18-29
30-39
40-49
50-59
60-69
70-79
80+
7. Gender

Woman
Man
Other
Prefer not to answer
8. Race and/or Ethnicity

3. If given a choice of vaccines, which do

you prefer?
Pfizer vaccine
Moderna vaccine
Will not take the vaccine
Prefer not to answer
4. Have you any concerns about taking the

COVID-19 vaccine?
Yes
No
Not sure
Prefer not to answer
5. If you have concerns about taking the

COVID-19 vaccine, please list your
concerns in the box below.
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American Indian or Alaskan Native
Asian
Black/African American
Hispanic or Latino
Native Hawaiian or other
Pacific Islander
White/Caucasian
Prefer not to answer
9. Role at KSU

Student
Staff Faculty
Administrator
Other
Prefer not to answer
This concludes the survey. Thank you for
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your participation!

https://digitalcommons.kennesaw.edu/kjur/vol9/iss1/2

20

